Preclinical and translational vaccine development for HIV and other candidate agents

Award Notice Posted

Solicitation number
75N93019R00023
Agency
Awarded
to Mriglobal
Set-aside
Partial Small Business

Opportunity facts

Contract number
75N93022D00002 Federal IDV award
Place of performance
Kansas City, Missouri 64110, United States

Notice details come from SAM.gov. Updated .

About this opportunity

MRIGlobal was awarded a blanket purchase agreement by the National Institutes of Health National Institute of Allergy and Infectious Diseases to provide preclinical and translational vaccine development services for HIV and other candidate agents. The maximum value of the award is $364,553,934 over a seven year period from December 1, 2021 through November 30, 2028. The award was made in response to solicitation number 75N93019R00023 to support the development of vaccines and other products through preclinical research activities.

Notice text

PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS

Awarded contract 75N93022D00002 to MRIGLOBAL for 364553934.00 on 2021-12-01.

Files

File Type Posted
Award Synopsis MRI.pdf PDF

Notice history

6 of 8 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors